Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2728459
Reference Type
Journal Article
Subtype
Abstract
Title
The oral toxicology of dichlorodifluoromethane
Author(s)
Sherman, H; Barnes, JR; Stula, EF
Year
1974
Is Peer Reviewed?
1
Journal
Toxicology and Applied Pharmacology
ISSN:
0041-008X
EISSN:
1096-0333
Volume
29
Issue
1
Page Numbers
152
Language
English
Relationship(s)
is part of a larger document
3378179
Abstracts of papers for the Thirteenth Annual Meeting of the Society of Toxicology, Washington, D.C. March 10–14, 1974
Abstract
Dichlorodifluoromethane has been in use since 1967 as an immersion freezing agent for food. Male and female rats have been administered dichlorodifluoromethane for 2 years by intra-gastric intubation at dose levels of 25-11 and 250-130 mg/kg, starting with offspring that had been exposed to the compound in utero. Except for a very slight decrease in the rate of body weight gain by animals that received the higher dose level, no clinical signs of toxicity were observed. The oral administration of the test compound did not affect mortality, nor did it alter any of the clinical laboratory measurements (hematology, urine analysis, liver function test). After 16 months, there was no histologic evidence of toxicity attributable to the administration of the dichlorodifluoromethane. The compound was not teratogenic to rats; it did not interfere with reproduction and lactation, and it did not alter the dominant lethal mutation index in rats. Dichlorodifluoromethane has also been administered in the diet to dogs for 2 years at levels of 300 ppm (ca. 10 mg/kg) and 3000 ppm (ca. 100 mg/kg) without any evidence of toxicity.
Conference Name
Thirteenth Annual Meeting of the Society of Toxicology
Conference Location
Washington, D.C.
Conference Dates
March 10–14, 1974
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity